This company has been marked as potentially delisted and may not be actively trading. NASDAQ:BSGM Biosig Technologies (BSGM) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Biosig Technologies Stock (NASDAQ:BSGM) Get Biosig Technologies alerts:Sign Up Key Stats Today's Range$4.36▼$6.1250-Day Range$3.68▼$6.3552-Week Range$0.59▼$14.11Volume3.10 million shsAverage Volume1.08 million shsMarket Capitalization$199.35 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Biosig Technologies, Inc. is a clinical-stage medical device company developing advanced signal acquisition and processing systems for interventional electrophysiology. Its lead product, the PURE EP™ System, is designed to enhance the quality and reliability of intracardiac recordings during diagnostic and therapeutic procedures for cardiac arrhythmias, including atrial fibrillation and other rhythm disorders. The PURE EP™ System integrates proprietary hardware and software to deliver higher-fidelity electrograms, helping physicians distinguish true cardiac signals from noise. Biosig Technologies is collaborating with electrophysiology labs and research institutions across the United States to conduct clinical studies and support regulatory filings aimed at expanding market access for its platform. Founded in the early 2010s and headquartered in New York, Biosig Technologies has pursued U.S. Food and Drug Administration (FDA) regulatory clearance for its flagship device and initiated preparations for European CE mark registration. The company’s pipeline also includes software upgrades and ancillary tools intended to further improve procedural workflows and patient outcomes. Under the leadership of President and Chief Executive Officer Kenneth L. Londoner, Biosig Technologies is positioning its PURE EP™ platform to address unmet needs in the growing field of cardiac rhythm management. By offering enhanced signal clarity and analytic capabilities, the company aims to become a preferred partner for electrophysiologists seeking innovative technologies to optimize interventional procedures.AI Generated. May Contain Errors. Read More Receive BSGM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Biosig Technologies and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BSGM Stock News HeadlinesStreamex Corp., NASDAQ: STEX & Simplify Asset Management $10 billion USD AUM ETF Manager Announces Letter of Intent Pursuing a Strategic Partnership to Drive ETF Innovation through Integration of Tokenized Gold Yield Assets and Tokenization of Existing ETFsSeptember 17, 2025 | globenewswire.comStreamex Corp., NASDAQ: STEX & Simplify Asset Management $10 billion USD AUM ETF Manager Announces Letter of Intent Pursuing a Strategic Partnership to Drive ETF Innovation through Integration of Tokenized Gold Yield Assets and Tokenization of Existing ETFsSeptember 17, 2025 | globenewswire.comThe end may be near for these iconic stocksMarc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are triggering a historic wealth transfer already underway in 2026. Household names like Intuit (-57%), Boston Scientific (-49%), and Tractor Supply (-40%) are cratering, while lesser-known companies like Sandisk (+573%) and Rackspace (+444%) surge. Chaikin has identified specific stocks he believes investors should sell before they fall further - and the names may surprise you. He's also pinpointing a company tapped as Nvidia's self-driving partner and a potential AI megadeal that could split into three high-growth stocks. Stream his free presentation to get every buy and sell recommendation with no membership or credit card required.August 4 at 1:00 AM | Chaikin Analytics (Ad)BioSig Technologies changing name to Streamex, ticker to ‘STEX’September 10, 2025 | msn.comBioSig Technologies, Inc. Announces Corporate Rebrand to Streamex Corp.September 10, 2025 | globenewswire.comMonetary Metals Enters into Exclusive Partnership with Streamex (Nasdaq: BSGM) to Create Tokenized Yield-Bearing Gold ProductsSeptember 9, 2025 | prnewswire.comBiosig Technologies trading halted, news pendingSeptember 8, 2025 | msn.comBioSig Technologies Partners with Monetary Metals for BlockchainSeptember 8, 2025 | msn.comSee More Headlines BSGM Stock Analysis - Frequently Asked Questions How were Biosig Technologies' earnings last quarter? Biosig Technologies, Inc. (NASDAQ:BSGM) released its quarterly earnings data on Friday, August, 15th. The company reported ($0.74) EPS for the quarter, missing the consensus estimate of ($0.04) by $0.70. When did Biosig Technologies' stock split? Biosig Technologies's stock reverse split before market open on Friday, February 2nd 2024.The 1-10 reverse split was announced on Friday, February 2nd 2024. The number of shares owned by shareholders was adjusted after the market closes on Friday, February 2nd 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. What other stocks do shareholders of Biosig Technologies own? Based on aggregate information from My MarketBeat watchlists, some other companies that Biosig Technologies investors own include NVIDIA (NVDA), Meta Platforms (META), Tesla (TSLA), Advanced Micro Devices (AMD), Citius Pharmaceuticals (CTXR), Roku (ROKU) and Ford Motor (F). Company Calendar Last Earnings8/15/2025Today8/04/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorFinance Industry Capital Markets Sub-IndustryAsset Management & Custody Banks Current SymbolNASDAQ:BSGM CIK1530766 Webwww.biosig.com Phone(230) 409-5444FaxN/AEmployees50Year Founded2009Profitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$10.33 million Net MarginsN/A Pretax Margin-201,392.33% Return on Equity-5,336.99% Return on Assets-90.03% Debt Debt-to-Equity RatioN/A Current Ratio0.03 Quick Ratio0.03 Sales & Book Value Annual Sales$13 thousand Price / Sales15,334.89 Cash FlowN/A Price / Cash FlowN/A Book Value($0.09) per share Price / Book-70.50Miscellaneous Outstanding Shares31,419,000Free Float23,627,000Market Cap$199.35 million OptionableNo Data Beta1.82 Social Links Don't Wait for the OpenAI IPOThe AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.Get This Free Report This page (NASDAQ:BSGM) was last updated on 8/4/2026 by MarketBeat.com Staff. From Our PartnersSMX: A Tiny Ticker with a Massive Global Growth Story!SMX (Security Matters) is building technology designed to solve one of sustainability's biggest problems: prov...Smallcaps Daily | SponsoredYour book attachedBill Poulos is giving away his 'Simple Options Trading For Beginners' book at no cost - normally $29.97. It ou...Profits Run | SponsoredTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...Porter & Company | Sponsored1 Stock to Own by July 31stA scheduled announcement on July 31st could reshuffle the stock market's winners and losers - and one lesser-k...Chaikin Analytics | SponsoredHe bet half his $9 billion on ONE stockOne of the most successful fund managers of the past 50 years put more than $4.5 billion - over half his fund ...Stansberry Research | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredNvidia's CEO says this small device is critical for AI growthA tiny glass device smaller than a fingertip could redefine AI hardware. Nvidia CEO Jensen Huang calls it esse...Brownstone Research | SponsoredCentral banks bought 710 tonnes - this fund pays monthlyGold is hitting new highs, fueled by tariffs and record central bank demand - 710 tonnes per quarter. JPMorgan...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biosig Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biosig Technologies With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
